BCR—ABL35INS突变型慢性粒细胞白血病患者选用酪氨酸激酶抑制剂的文献分析(5)
[15] MA W，GILES F，ZHANG X，et al. Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors[J]. Int Jnl Lab Hem，2011，33(3)：326-331.
[16] STRHAKOVA L，GERYKOVA BM，HOJSIKOVA I，et al. Use of direct sequencing for detection of mutations in the BCR-ABL kinase domain in Slovak patients with chronic myeloid leukemia[J]. Neoplasma，2011，58(6)：548-553.
[17] HEHLMANN R，HOCHHAUS A，BACCARANI M. Chronic myeloid leukaemia[J]. Lancet，2007，370(9584)：342-350.
[18] National Cancer Institute. Common terminology criteria for adverse events(CTCAE)V3.0：2010[S]. 2011-10-18.
[19] THOTA NK，GUNDETI S，LINGA VG，et al. Imatinib me- sylate as first-line therapy in patients with chronic mye- loid leukemia in accelerated phase and blast phase：a retrospective analysis[J]. Indian J Cancer，2014，51(1)：5-9.
[20] MA W，KANTARJIAN H，YEH C，et al. BCR-ABL truncation due to premature translation termination as a me- chanism of resistance to kinase inhibitors[J]. Acta Haematol，2009，121(1)：27-31.
[21] MAHADEO KM，COLE PD. Successful treatment using omacetaxine for a patient with CML and BCR-ABL35INS[J].Blood，2010. DOI：10.1182/blood-2010-02-269233.
(收稿日期：2018-08-14 修回日期：2019-04-11)
(編辑：张元媛), 百拇医药(闫美玲 张萌 黄琳 贾月萍 张弋 冯婉玉 高慧儿)
[16] STRHAKOVA L，GERYKOVA BM，HOJSIKOVA I，et al. Use of direct sequencing for detection of mutations in the BCR-ABL kinase domain in Slovak patients with chronic myeloid leukemia[J]. Neoplasma，2011，58(6)：548-553.
[17] HEHLMANN R，HOCHHAUS A，BACCARANI M. Chronic myeloid leukaemia[J]. Lancet，2007，370(9584)：342-350.
[18] National Cancer Institute. Common terminology criteria for adverse events(CTCAE)V3.0：2010[S]. 2011-10-18.
[19] THOTA NK，GUNDETI S，LINGA VG，et al. Imatinib me- sylate as first-line therapy in patients with chronic mye- loid leukemia in accelerated phase and blast phase：a retrospective analysis[J]. Indian J Cancer，2014，51(1)：5-9.
[20] MA W，KANTARJIAN H，YEH C，et al. BCR-ABL truncation due to premature translation termination as a me- chanism of resistance to kinase inhibitors[J]. Acta Haematol，2009，121(1)：27-31.
[21] MAHADEO KM，COLE PD. Successful treatment using omacetaxine for a patient with CML and BCR-ABL35INS[J].Blood，2010. DOI：10.1182/blood-2010-02-269233.
(收稿日期：2018-08-14 修回日期：2019-04-11)
(編辑：张元媛), 百拇医药(闫美玲 张萌 黄琳 贾月萍 张弋 冯婉玉 高慧儿)